5251 - 5260 of 8404 Results
Title
Year
-
OPENTitle: Freezing of Gait and Its Levodopa ParadoxJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 287End Page: 287Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4006Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/225524/225524.pdfCitation Count: 49
- Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study2019OPENTitle: Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 45Issue #: 4Start Page: 632End Page: 640Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-019-0589-zBest OA location URL: https://www.nature.com/articles/s41386-019-0589-z.pdfCitation Count: 56
- Multimodal Balance Training Supported by Rhythmical Auditory Stimuli in Parkinson’s Disease: A Randomized Clinical Trial2019OPENTitle: Multimodal Balance Training Supported by Rhythmical Auditory Stimuli in Parkinson’s Disease: A Randomized Clinical TrialJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 333End Page: 346Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191752Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191752?id=journal-of-parkinsons-disease%2Fjpd191752Citation Count: 37
- The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease2019RESTRICTEDTitle: The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 295End Page: 295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.3983Citation Count: 13
-
RESTRICTEDTitle: Movement disorders in 2019: from antibodies to lifestyle interventionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 10End Page: 12Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7Citation Count: 1
-
RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019RESTRICTEDTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12874Citation Count: 27
- Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study2019RESTRICTEDTitle: Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 51End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.008Citation Count: 32
-
OPENTitle: Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 577Issue #: 7788Start Page: 103End Page: 108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-019-1828-5Best OA location URL: https://europepmc.org/articles/pmc6930849?pdf=renderCitation Count: 269